There is currently no absolute cause of MS, which presents a challenge to discover a cure as well.However, there are many treatments, including physical therapy, available to help manage the symptoms of this disease.Tags: Business Plan For StudentsHomeworks IncWhat To Write My College Essay AboutShould School Start Later In The Morning Persuasive EssayDissertation Express ProquestEasy Environmental Science Essay TopicsDifferent Types Of Essays To WriteConclusion Of AssignmentPhoto Essay High School Assignment
These cells are normally located in the brain’s gray matter.... Destructionof the membrane leads to slowed conveyance of signals from the spinal cord to the brain, which as a result leads to reduced response to different stimuli....
Peter Calabresi serves on the national steering committees for both of these trials.
The MS Center is also participating in a trial of daclizumab, another monoclonal antibody that has shown promise in the treatment of relapsing-remitting MS. Calabresi recently led the phase 3 trial of a long-acting interferon beta drug, pegylated intereferon, that was recently FDA approved and will enable people with MS to dose their medication only every two weeks. Ellen Mowry is leading a study of vitamin D supplementation to determine if this approach can help people with MS when combined with a standard therapy.
Multiple Sclerosis Research at Johns Hopkins Hear from Dr.
Peter Calabresi, director of the Johns Hopkins Multiple Sclerosis Center, what research is being done to develop new diagnostic and treatment options for MS.